COMMUNIQUÉS West-GlobeNewswire

ORYZON Presents Data From ETHERAL Phase IIa Trial at the 2019 Alzheimer's Association International Conference in Los Angeles
16/07/2019
ETHERAL has recruited more than 100 patients to date Safety data so far show that vafidemstat is safe and well tolerated Parametric functional evolution of the first (blinded) 33 patients that have been treated for 6 [...]
The New Hemp Energy Drink Will Soon Be Available In More Than 500 Stores in Quebec
16/07/2019
OTTAWA, ON, July 16, 2019 (GLOBE NEWSWIRE) -- Tetra Natural Health Inc., a division of Tetra Bio-Pharma Inc. (TSX VENTURE: TBP) (OTCQB: TBPMF), today announced that it has signed an agreement with Distribution AB inc. [...]
Le nouveau Hemp Energy Drink sera disponible dans plus de 500 points de vente au Québec
16/07/2019
OTTAWA, ON, 16 juill. 2019 (GLOBE NEWSWIRE) -- Tetra Santé Naturelle, une filiale de Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), annonce la conclusion d’une entente avec Distribution AB inc. pour la distribution [...]
MediWound to Host Analyst Day on its Innovative Product EscharEx® for Debridement of Chronic Wounds
16/07/2019
YAVNE, Israel, July 16, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, will [...]
Eloxx Pharmaceuticals to Report Second Quarter 2019 Financial Results and Provide Business Update on August 7, 2019
16/07/2019
Company management to host a webcast and conference call to provide a business update and review financial results at 8:30 a.m. ET WALTHAM, Mass., July 16, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: [...]
Spero Therapeutics Announces $5.9 Million Award from U.S. Department of Defense to Further Clinical Development of SPR206
16/07/2019
CAMBRIDGE, Mass., July 16, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]
Trefoil Therapeutics Raises $28 Million Series A to Advance Engineered FGF-1 for the Treatment of Corneal Diseases
16/07/2019
Lead candidate TTHX1114 will advance to IND and clinical study in corneal endothelial disease in early 2020 SAN DIEGO, July 16, 2019 (GLOBE NEWSWIRE) -- Trefoil Therapeutics announced it raised $28 million in an [...]
Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate Update
16/07/2019
~ Expects to Report Second Quarter 2019 Net Product Sales of Approximately $13.8 Million, Which Represents an Increase of 17 Percent Over the First Quarter of 2019 ~ ~ Anticipates Having Approximately $90 Million of [...]
Immunotherapy Company Enlivex Announces Dual Listing on the Tel-Aviv Stock Exchange
16/07/2019
The Company's shares, which currently trade on NASDAQ , will be dual-listed on the Tel Aviv Stock Exchange (TASE) starting on July 22, 2019, under the symbol ENLV Tel-Aviv, Israel, July 16, 2019 (GLOBE NEWSWIRE) -- [...]
CURE Pharmaceutical [OTCQB:CURR] Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients
16/07/2019
OXNARD, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No. 15/666,057, which covers [...]
Aptose Doses First CLL Patient in Phase 1 Study of CG-806 and Doses Third Cohort in Phase 1 Study of APTO-253
16/07/2019
– CG-806 oral non-covalent pan-FLT3/pan-BTK inhibitor being developed for the treatment of CLL and other B-cell malignancies and for AML – – APTO-253 MYC inhibitor being developed for the treatment of AML and MDS – SAN [...]
hATTR Compass™ Genetic Testing Program Continues to Expand and Enable Diagnosis and Treatment of Hereditary ATTR Amyloidosis One Year Following Launch
16/07/2019
Akcea and Ambry Genetics grow partnership, providing easily accessible, no-cost, confidential genetic testing and genetic counseling services to people with suspected hereditary ATTR amyloidosis BOSTON and Aliso Viejo, [...]
Notable Announces $40M Series B Round to Fuel Development of Its Drug Discovery Platform for Personalized Oncology
16/07/2019
B Capital Group and LifeForce Capital Co-Lead Investment to Accelerate Notable’s Automated Lab, AI Technology, and Precision Drug Discovery SAN FRANCISCO, July 16, 2019 (GLOBE NEWSWIRE) -- Notable , which is redefining [...]
IRADIMED CORPORATION to Hold 2019 Second Quarter Financial Results Conference Call on July 30th
16/07/2019
WINTER SPRINGS, Fla., July 16, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 second quarter financial results before the market opens on Tuesday, [...]
Kymab Appoints Catherine Moukheibir as Non-Executive Director
16/07/2019
Kymab Appoints Catherine Moukheibir as Non-Executive Director Cambridge, UK; July 16, 2019 : Kymab, a clinical-stage biopharmaceutical company developing antibody-based therapeutics, announces the appointment of [...]
Inivata Signs Distribution Agreement with IPS Genomix for InVision® Genomic Tests in the Middle East and Africa
16/07/2019
Inivata Signs Distribution Agreement with IPS Genomix for InVision ® Genomic Tests in the Middle East and Africa Research Triangle Park, NC, USA and Cambridge, UK, and Dubai, UAE , July 16, 2019 -- Inivata , a leader in [...]
YSS Corp. Announces Receipt of Eleventh Retail Cannabis Store License
16/07/2019
CALGARY, Alberta, July 16, 2019 (GLOBE NEWSWIRE) -- YSS Corp.™ (the “ Company ” or “ YSS ”) (TSXV: YSS) (WKN: A2PMAX) is pleased to announce the receipt of an additional cannabis retail license from the Alberta Gaming, [...]
Atara Biotherapeutics Announces Plan to Initiate Tab-cel® FDA Biologics License Application Submission Next Year
16/07/2019
SOUTH SAN FRANCISCO, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Kane Biotech Announces New Agreement with FreeMind Group
16/07/2019
WINNIPEG, Manitoba, July 16, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]

Pages